We are live on ! Find out more
KA

Klingman & Associates Portfolio holdings

AUM $2.35B
1-Year Est. Return 23.18%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+23.18%
3 Year Est. Return
+59.34%
5 Year Est. Return
+62.44%
10 Year Est. Return
+178.86%
AUM
$1.48B
AUM Growth
+$38.9M
Cap. Flow
+$63.6M
Cap. Flow %
4.29%
Top 10 Hldgs %
52.11%
Holding
255
New
19
Increased
107
Reduced
75
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 6.81%
2 Financials 3.56%
3 Consumer Discretionary 1.51%
4 Healthcare 0.78%
5 Communication Services 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFIV icon
176
Dimensional International Value ETF
DFIV
$21.3B
$349K 0.02%
9,721
FRA icon
177
BlackRock Floating Rate Income Strategies Fund
FRA
$383M
$347K 0.02%
26,786
+753
+3% +$9.84K
VBK icon
178
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$345K 0.02%
1,381
-26
-2% -$6.49K
MRNA icon
179
Moderna
MRNA
$21.8B
$345K 0.02%
2,906
+18
+0.6% +$2.28K
WSM icon
180
Williams-Sonoma
WSM
$26.9B
$345K 0.02%
2,444
-62
-2% -$9.24K
GS icon
181
Goldman Sachs
GS
$300B
$345K 0.02%
763
+5
+0.7% +$2.19K
AMD icon
182
Advanced Micro Devices
AMD
$776B
$334K 0.02%
2,057
+15
+0.7% +$2.41K
GIS icon
183
General Mills
GIS
$19.1B
$333K 0.02%
5,262
CL icon
184
Colgate-Palmolive
CL
$73.1B
$331K 0.02%
3,412
+49
+1% +$4.52K
QUAL icon
185
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$326K 0.02%
1,912
CACC icon
186
Credit Acceptance
CACC
$5.95B
$326K 0.02%
633
-98
-13% -$49.9K
VZ icon
187
Verizon
VZ
$195B
$309K 0.02%
7,502
-5,623
-43% -$227K
VSS icon
188
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$308K 0.02%
2,624
+328
+14% +$38.5K
ISRG icon
189
Intuitive Surgical
ISRG
$127B
$303K 0.02%
681
+173
+34% +$68.9K
SUSA icon
190
iShares ESG Optimized MSCI USA ETF
SUSA
$4.01B
$303K 0.02%
2,694
PM icon
191
Philip Morris
PM
$297B
$302K 0.02%
2,983
+233
+8% +$22.8K
SYK icon
192
Stryker
SYK
$125B
$298K 0.02%
+877
New +$297K
FFIV icon
193
F5
FFIV
$22.9B
$297K 0.02%
1,726
+7
+0.4% +$1.22K
SCHW
194
Charles Schwab
SCHW
$183B
$297K 0.02%
4,032
+198
+5% +$14.6K
CVS icon
195
CVS Health
CVS
$133B
$296K 0.02%
5,012
-246
-5% -$15.4K
QCOM icon
196
Qualcomm
QCOM
$155B
$294K 0.02%
1,475
+29
+2% +$5.48K
HLT icon
197
Hilton Worldwide
HLT
$72.1B
$290K 0.02%
1,327
+31
+2% +$6.37K
EQR icon
198
Equity Residential
EQR
$24.9B
$289K 0.02%
4,168
-911
-18% -$59.3K
CMCSA icon
199
Comcast
CMCSA
$85B
$286K 0.02%
7,298
+1,046
+17% +$40.9K
TXN icon
200
Texas Instruments
TXN
$252B
$284K 0.02%
1,460
+310
+27% +$57.3K

Similar funds

Klingman & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Klingman & Associates held 255 positions worth $1.48B, up 2.7% from $1.44B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Klingman & Associates deployed $63.6M of net new capital in Q2 2024, opening 19 new positions and adding to 107 existing holdings. Its largest new stake was iShares iBonds Dec 2027 Term Corporate ETF: 1,024,075 shares worth $24.3M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 6.1% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, an estimated $2.84M trimmed.

  • Klingman & Associates's largest Q2 2024 buy was iShares iBonds Dec 2027 Term Corporate ETF: 1,024,075 shares worth $24.3M.
  • Klingman & Associates added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $5.65M increase.
  • Klingman & Associates's biggest Q2 2024 reduction was FlexShares iBoxx 3-Year Target Duration TIPS Index Fund, cutting an estimated $2.84M.
  • Klingman & Associates fully exited Royal Bank of Canada in Q2 2024, selling an estimated $529K.
  • Klingman & Associates's ten largest holdings make up 52% of its $1.48B portfolio in Q2 2024.
  • Klingman & Associates opened 19 new positions and closed 6 in Q2 2024.
  • Klingman & Associates's portfolio value rose 2.7% quarter-over-quarter to $1.48B.

Based on Klingman & Associates's 13F filing for Q2 2024, filed 30 Jul 2024.